Differences in Adherence to Common Inhaled Medications in COPD

References

• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/ (accessed 11 December, 2012).
   Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645–2653.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64(11):939–943.
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63(9):831–838.
   PubMed Web of Science ®Google Scholar
• George J, Kong DC, Thoman R, et al. Factors associated with medication nonadherence in patients with COPD. Chest 2005; 128(5):3198–3204.
   PubMed Web of Science ®Google Scholar
• Baiardini I, Braido F, Bonini M, et al. Why do doctors and patients not follow guidelines? CurrOpin Allergy ClinImmunol 2009; 9(3):228–233.
   PubMed Web of Science ®Google Scholar
• Tashkin DP. Multiple dose regimens. Impact on compliance. Chest 1995; 107(5 Suppl):176S–182S.
   PubMed Web of Science ®Google Scholar
• Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(3):371–384.
   PubMedGoogle Scholar
• van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res 2014; 15:66.
   PubMed Web of Science ®Google Scholar
• Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD 2012; 9(3):25–25-8.
   Google Scholar
• Krigsman K, Moen J, Nilsson JL, et al. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007; 32(6):603–611.
   PubMed Web of Science ®Google Scholar
• Ismaila A, Corriveau D, Vaillancourt J, et al. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Curr Med Res Opin 2014; 30(7):1427–1436.
   PubMed Web of Science ®Google Scholar
• Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy ClinImmunol 2006; 118(4):899–904.
   PubMed Web of Science ®Google Scholar
• Mehuys E, Boussery K, Adriaens E, et al. COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother 2010; 44(2):257–266.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. EurRespir J Suppl 1993; 16:5–40.
   PubMedGoogle Scholar
• van der Lende R, Jansen-Koster EJ, Knijpstra S, et al. [Prevalence of cold in Vlagtwedde and Vlaardingen (computer diagnosis versus doctors’ diagnosis)]. Ned TijdschrGeneeskd 1975; 119(50):1988–1996.
   PubMedGoogle Scholar
• Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11(7):449–457.
   PubMed Web of Science ®Google Scholar
• van Grunsven PM, van Schayck CP, van DM, et al. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000; 37(3):225–234.
   PubMed Web of Science ®Google Scholar
• From: SPC tekstOxisTurbohaler 12, inhalation powder. Available from: https://www.medicines.org.uk/emc/medicine/190. (accessed 21 October, 2014).
   Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. ClinTher 2001; 23(8):1296–1310.
   Google Scholar
• Stichting Farmaceutische Kengetallen. Therapy adherence data on Astma/COPD patients in the Netherlands including regional differences. Available from: http://www.therapietrouwmonitor.nl (accessed 27 November, 2012).
   Google Scholar
• Alagha K, Palot A, Sofalvi T, et al. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. TherAdv Chronic Dis 2014; 5(2):85–98.
   PubMedGoogle Scholar
• Available from: https://www.nhg.org/nhg-standaarden (accessed 24 March, 2014).
   Google Scholar
• Available from: http://www.diliguide.nl/document/zoeken/?q=COPD&search[cats][t][]=21&search[year][opt]=in& (accessed 24 March, 2014).
   Google Scholar
• Elkout H, Helms PJ, Simpson CR, et al. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. PLoS One 2012; 7(6):e39130.
   PubMed Web of Science ®Google Scholar
• Turner J, Wright E, Mendella L, et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995; 108(2):394–400.
   Google Scholar
• Simmons MS, Nides MA, Rand CS, et al. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118(2):290–295.
   PubMed Web of Science ®Google Scholar
• Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008; 30(5):509–514.
   PubMed Web of Science ®Google Scholar
• Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37(9):846–857.
   PubMed Web of Science ®Google Scholar